A panel of federal judges is scheduled to hear arguments next month over whether all Propecia lawsuits should be centralized. The suits have all been filed by men who developed erectile dysfunction and other sexual problems after using the popular Propecia for hair loss.
The U.S. Judicial Panel on Multidistrict Litigation is set to hear arguments on March 29 in San Diego, at which point lawyers for the drug maker and various plaintiffs involved in the Propecia litigation will present arguments on whether the cases should be consolidated before one judge for pretrial proceedings as part of an MDL, according to aboutlawsuits.com.
The attempt to centralize is being made because there are more than 50 lawsuits over Propecia pending in courts across the nation, all of which include similar allegations that Merck & Co. failed to adequately warn consumers or medical professionals that side effects of Propecia could cause permanent or long-lasting sexual problems.
Merck has suggested on the warning label that any sexual side effects of Propecia are temporary; claiming that cases observed during clinical trials resolved after users stopped taking the drug.
Many of the plaintiffs and Merck agree that the cases should be centralized as part of a Propecia MDL (multidistrict litigation), but disagree on where the cases should be transferred.
One plaintiff believes the cases should be centralized in the District Court for the Eastern District of New York. However, Merck disagrees, recommending the cases be consolidated in New Jersey since 41 of the 53 lawsuits were there.